Loading...
Loading...
India's carboplatin imports from CHINA total $1.4K across 1 shipments from 1 foreign suppliers. BIO-THERA SOLUTIONS LTD leads with $1.4K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include IQVIA RDS (INDIA) PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for carboplatin — a concentrated sourcing relationship with select suppliers from CHINA.

BIO-THERA SOLUTIONS LTD is the leading Carboplatin supplier from CHINA to India, with import value of $1.4K across 1 shipments. The top 5 suppliers — BIO-THERA SOLUTIONS LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIO-THERA SOLUTIONS LTD | $1.4K | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IQVIA RDS (INDIA) PRIVATE LIMITED | $1.4K | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Carboplatin suppliers from CHINA to India include BIO-THERA SOLUTIONS LTD. The leading supplier is BIO-THERA SOLUTIONS LTD with import value of $1.4K USD across 1 shipments. India imported Carboplatin worth $1.4K USD from CHINA in total across 1 shipments.
India imported Carboplatin worth $1.4K USD from CHINA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Carboplatin sourced from CHINA include IQVIA RDS (INDIA) PRIVATE LIMITED. The largest buyer is IQVIA RDS (INDIA) PRIVATE LIMITED with $1.4K in imports across 1 shipments.
The total value of Carboplatin imports from CHINA to India is $1.4K USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists